Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ILMNthis companyIllumina, Inc.	$218.79	24.54×	7.65×	4.81×	15.09×	-124.1%	66.7%	19.9%	19.6%	31.2%	12.0%	4.5%	0.94×	0.78×	8.55×	2.08×	0.0%	7	7.4	3	B
BLLNBillionToOne, Inc.	$113.55	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
GHGuardant Health, Inc.	$157.35	-30.77×	-128.95×	13.04×	-37.81×	-214.8%	64.5%	-44.5%	-42.4%	419.2%	-25.1%	-1.8%	-17.22×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	C
MYGNMyriad Genetics, Inc.	$5.77	-1.55×	1.56×	0.7×	-1.92×	-408.9%	69.9%	-8.2%	-44.4%	-99.4%	-10.8%	-4.5%	0.57×	-0.18×	-6.46×	2.49×	0.0%	4	-0.56	1	C-
NEONeoGenomics, Inc.	$17.29	-14×	1.8×	2.07×	-15.87×	-168.7%	38.8%	-9.1%	-14.9%	-12.9%	-5.1%	-1.4%	0.56×	-8.08×	-17.61×	4.26×	0.0%	4	2.5	1	C-
NTRANatera, Inc.	$321.88	-150.72×	18.29×	13.58×	-138.12×	-182.4%	64.8%	-13.4%	-9.0%	-12.2%	-11.1%	0.3%	0.13×	3.91×	-76.16×	3.39×	0.0%	3	42.53	1	C-
Peer median	—	-14×	1.8×	12.29×	-15.87×	-182.4%	64.8%	-9.1%	-14.9%	-12.2%	-10.8%	-1.4%	0.23×	-3.56×	-17.61×	4.26×	0.0%	4	4.87	1	—